癌症药品定价的决定因素以及如何克服癌症溢价。
Determinants of cancer drug pricing and how to overcome the cancer premium.
发表日期：2023 Apr 13
作者：
Kerstin N Vokinger
来源：
CELL
摘要：
癌症药品高价并不断上涨，是公共健康面临的挑战。为了打破癌症价格溢价，提高患者获得癌症药品的机会，必须采取不同的行动步骤：更多透明的价格决定过程和实际价格，以价值为基础的定价，以及“价格与证据开发”。 版权所有©2023 Elsevier Inc.。保留所有权利。
The high and increasing prices of cancer drugs are a public health challenge. To disrupt the cancer premium and improve patient access to cancer drugs, different action steps are indicated: more transparency on the price determination process and actual prices, value-based pricing, and "price with evidence development."Copyright © 2023 Elsevier Inc. All rights reserved.